Policy Prescriptions for Cost & Coverage

From delaying medical care and putting off doctor visits, to struggling to access adequate services ‒ health care in the traditional sense had largely been put on hold during the COVID-19 pandemic.

But now, as vaccines bring hope that the nation may soon begin to emerge from this crisis, longstanding concerns will have to be addressed. High out-of-pocket costs and surprise medical bills remain a top challenge for patients, as does the ability to access quality health insurance that meets their needs. How can we bring patient-centered solutions to the health care system and ensure its resiliency?

The Hill will sit down with policymakers, health care experts and patient advocates for a conversation about envisioning the post-pandemic picture of health care.

Tuesday, April 20

1:30 PM ET/10:30 AM PT

Speakers:

• Rep. Lisa Blunt Rochester (D-DE), Member, Subcommittee on Health, Committee on Energy and Commerce
• Keysha Brooks-Coley, VP, Federal Advocacy and Strategic Alliances, American Cancer Society Cancer Action Network
• Rep. Rodney Davis (R-IL), Co-Chair, Congressional Colorectal Cancer Caucus & Task Force on Childhood Obesity

Sponsor Perspective:

• Lori M. Reilly, Chief Operating Officer, PhRMA
• Benjie Fido, Caregiver to son with medical condition

Moderator:

• Steve Clemons, Editor-at-Large, The Hill

Questions for our speakers? Join the conversation using @TheHillEvents and #TheHillPolicyRx.

SPONSORED CONTENT MESSAGE

Discussions about medicine costs are important. We are in a new era of medicine where breakthrough science is transforming patient care, but these innovations are meaningless if patients can’t afford them. That is why we are convening a conversation about medicine cost.

Insurers, PBMs and others got nearly 50% of what Americans spent on brand medicines in 2018, and their share is increasing every year. Helping patients means looking at the whole picture. We need to fix this broken system to ensure savings in the health care system go to patients – not middlemen. Learn more.